Clinical Trial Update: A Phase II Study to Evaluate the Efficacy and Safety of of DR10624 in Subjects With Severe Hypertriglyceridemia [Phase 2]

View source ↗

Summary

Phase II clinical trial of DR10624 for severe hypertriglyceridemia has completed; the snippet provides no efficacy or safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• DR10624

Snippet

Sponsor: Zhejiang Doer Biologics Co., Ltd. | Conditions: Severe Hypertriglyceridemia | Phase 2 | Status: COMPLETED